Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
about
The Yin and Yang of Toll-like receptors in cancerPattern-recognition receptors and gastric cancerRole of TLR4 rs4986790A>G and rs4986791C>T Polymorphisms in the Risk of Inflammatory Bowel DiseaseGenetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: a prospective cross-sectional study in Thailand.Pattern recognition receptors and DNA repair: starting to put a jigsaw puzzle togetherLBP and CD14 polymorphisms correlate with increased colorectal carcinoma risk in Han Chinese.Role of toll-like receptor 4 in colorectal carcinogenesis: a meta-analysisToll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas.Toll-Like Receptor 4 Wild Type Homozygozity of Polymorphisms +896 and +1196 Is Associated with High Gastrin Serum Levels and Peptic Ulcer Risk.Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?The influence of cytokine gene polymorphisms on the risk of developing gastric cancer in patients with Helicobacter pylori infection.Effects of polymorphisms of innate immunity genes and environmental factors on the risk of noncardia gastric cancer.Correlation of Asp299Gly and Thr399Ile polymorphisms in toll-like receptor 4 gene with digestive cancer risk: A meta-analysis.Gene polymorphisms: the keys for marker assisted selection and unraveling core regulatory pathways for mastitis resistance.Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis.Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells.Toll-Like Receptor 4 Signaling in High Mobility Group Box-1 Protein 1 Mediated the Suppression of Regulatory T-CellsPathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation.Determination of the Relationship Between rs4986790 and rs4986791 Variants of TLR4 Gene and Lung Cancer.Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.Association of Polymorphisms in Toll-Like Receptors 4 and 9 with Autoimmune Thyroid Disease in Korean Pediatric Patients.Vitamin D receptor gene polymorphism Fok I in the Polish population does not contribute to the risk of systemic lupus erythematosus.Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report.Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.Association of Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile with the risk of primary open angle glaucoma.Association of single-nucleotide polymorphisms in non-coding regions of the TLR4 gene with primary open angle glaucoma in a Mexican population.Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer.
P2860
Q26851526-462C72A4-94A2-4086-B575-79BE987B0327Q26991941-99904A30-BE01-4A6B-905F-16C5F9500F4EQ28081072-0B8AC365-723D-41C0-B7AC-551B63A51F5DQ30491296-4945C808-F1DA-456B-BF48-DCAC34C07166Q33358901-93293115-8CD7-4F31-B2CD-5F1521E4069BQ34993700-8BF63263-E5CB-457E-B0D6-137ECB7B2D3DQ35140178-DA9E0969-909B-4B97-A748-1A72A0C689EDQ35207161-47D7AA8C-EBD3-4412-A4DD-19B74332AFDBQ35687790-7E70F30E-F594-459D-8B89-ED1D45E89584Q35832150-3440122F-DBDD-436D-871C-D9558DBC8236Q36079259-FCEF5BB8-EEB5-4C2A-A72A-CF7F97D38D90Q37484582-E9065690-B5DF-49A9-A780-D95BE1AFEA2EQ37641119-2FA0688F-8478-4D49-B19C-26419516B105Q37945498-157EACAC-C4F9-439F-B67C-52C59F40789BQ38099583-2BF3DF9D-964F-4939-9F71-8285032B69E3Q38838562-1B769731-3FB5-4A85-8264-A2D5E5765FB4Q39016015-912424A4-A0FE-45AB-8B6D-5FA0256DC57FQ39070506-0D356C56-B5E9-4B67-AD0B-342D07E8F36FQ39237511-3E906DFB-10FF-473A-8114-F499207DA24EQ40615323-ACAE8E4D-8D94-425C-857F-9DAC0098C323Q41020185-3DACDF2C-3C1D-45C2-BF5F-CC3EA0652CD0Q41622992-7523ACB7-C2E1-4C61-9E81-F95C7326F007Q44782920-3D8C3095-6F29-452F-A3C2-FFA5D87E04CFQ45245695-030A9278-2806-4E30-8E8D-CE1AE49DF331Q45360087-4270468D-E601-4024-8583-0EDE0F49FF16Q47985138-41E4B2D9-2BF7-4F3F-9BFF-F00794D63F1DQ50116299-3EB2337B-74EF-47E3-BDB0-D812C52C1723Q53154278-BA498065-D7A8-4F86-9BF1-4FCBC2954CA7
P2860
Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
@en
Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
@nl
type
label
Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
@en
Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
@nl
prefLabel
Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
@en
Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
@nl
P1433
P1476
Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
@en
P304
P356
10.1016/J.HUMIMM.2010.11.003
P577
2010-12-02T00:00:00Z